Loading clinical trials...
Loading clinical trials...
A Phase I Study Of CEP-701 In Patients With Refractory Neuroblastoma (IND # 67,722)
Conditions
Interventions
lestaurtinib
Locations
12
United States
Childrens Hospital Los Angeles
Los Angeles, California, United States
Lucille Salter Packer Children's Hospital, Stanford University
Palo Alto, California, United States
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus
Atlanta, Georgia, United States
University of Chicago Comer Children's Hospital
Chicago, Illinois, United States
Children's Hospital Boston
Boston, Massachusetts, United States
Start Date
August 1, 2003
Primary Completion Date
September 1, 2009
Completion Date
February 1, 2011
Last Updated
April 10, 2023
NCT06721689
NCT04308330
NCT06541262
NCT06057948
NCT04936529
NCT04851119
Lead Sponsor
New Approaches to Neuroblastoma Therapy Consortium
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions